ARTICLE | Clinical News
Aptivus tipranavir regulatory update
October 31, 2005 8:00 AM UTC
EC granted marketing approval for Aptivus tipranavir in combination with ritonavir to treat HIV-1 infection in highly pre-treated adult patients who are resistant to multiple protease inhibitors. The ...